Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Presta

Showing results (141-150 of 184) with videos related to

Pageof 19
Sort By:
The International Journal of Biochemistry & Cell Biology|November 13, 2007
Fibroblast growth factor-2 binding to the thrombospondin-1 type III repeats, a novel antiangiogenic domainBarbara Margosio, Marco Rusnati, Katiuscia Bonezzi, et al.
Brain : a Journal of Neurology|August 29, 2013
Inhibition of angiogenesis by β-galactosylceramidase deficiency in globoid cell leukodystrophyMirella Belleri, Roberto Ronca, Daniela Coltrini, et al.
Diabetes|February 20, 2015
Therapeutic Potential of Anti-Angiogenic Multitarget N,O-Sulfated E. Coli K5 Polysaccharide in Diabetic RetinopathySara Rezzola, Massimo Dal Monte, Mirella Belleri, et al.
Molecular Cancer Therapeutics|December 17, 2008
alphavbeta3 Integrin-dependent antiangiogenic activity of resveratrol stereoisomersMirella Belleri, Domenico Ribatti, Monica Savio, et al.
Investigative Ophthalmology & Visual Science|March 14, 2015
Antiangiogenic Effectiveness of the Urokinase Receptor-Derived Peptide UPARANT in a Model of Oxygen-Induced RetinopathyMassimo Dal Monte, Sara Rezzola, Maurizio Cammalleri, et al.
Brain : a Journal of Neurology|April 30, 2025
Brain accumulation of lactosylceramide characterizes GALC deficiency in a zebrafish model of Krabbe diseaseJessica Guerra, Mirella Belleri, Elisa Scalvini, et al.
Cancers|September 5, 2019
Long Pentraxin-3 Follows and Modulates Bladder Cancer ProgressionSara Matarazzo, Laura Melocchi, Sara Rezzola, et al.
Molecular Cancer Therapeutics|February 4, 2012
The thymidine phosphorylase inhibitor 5'-O-tritylinosine (KIN59) is an antiangiogenic multitarget fibroblast growth factor-2 antagonistSandra Liekens, Annelies Bronckaers, Mirella Belleri, et al.
Non-Coding RNA|May 5, 2019
Circulating microRNAs and Their Role in Multiple MyelomaCinzia Federico, Antonio Sacco, Angelo Belotti, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 24, 2012
Long pentraxin 3/tumor necrosis factor-stimulated gene-6 interaction: a biological rheostat for fibroblast growth factor 2-mediated angiogenesisDaria Leali, Antonio Inforzato, Roberto Ronca, et al.
Pageof 19

Showing results (141-150 of 184) with videos related to

Sort By:
Pageof 19
The International Journal of Biochemistry & Cell Biology|November 13, 2007
Fibroblast growth factor-2 binding to the thrombospondin-1 type III repeats, a novel antiangiogenic domainBarbara Margosio, Marco Rusnati, Katiuscia Bonezzi, et al.
Brain : a Journal of Neurology|August 29, 2013
Inhibition of angiogenesis by β-galactosylceramidase deficiency in globoid cell leukodystrophyMirella Belleri, Roberto Ronca, Daniela Coltrini, et al.
Diabetes|February 20, 2015
Therapeutic Potential of Anti-Angiogenic Multitarget N,O-Sulfated E. Coli K5 Polysaccharide in Diabetic RetinopathySara Rezzola, Massimo Dal Monte, Mirella Belleri, et al.
Molecular Cancer Therapeutics|December 17, 2008
alphavbeta3 Integrin-dependent antiangiogenic activity of resveratrol stereoisomersMirella Belleri, Domenico Ribatti, Monica Savio, et al.
Investigative Ophthalmology & Visual Science|March 14, 2015
Antiangiogenic Effectiveness of the Urokinase Receptor-Derived Peptide UPARANT in a Model of Oxygen-Induced RetinopathyMassimo Dal Monte, Sara Rezzola, Maurizio Cammalleri, et al.
Brain : a Journal of Neurology|April 30, 2025
Brain accumulation of lactosylceramide characterizes GALC deficiency in a zebrafish model of Krabbe diseaseJessica Guerra, Mirella Belleri, Elisa Scalvini, et al.
Cancers|September 5, 2019
Long Pentraxin-3 Follows and Modulates Bladder Cancer ProgressionSara Matarazzo, Laura Melocchi, Sara Rezzola, et al.
Molecular Cancer Therapeutics|February 4, 2012
The thymidine phosphorylase inhibitor 5'-O-tritylinosine (KIN59) is an antiangiogenic multitarget fibroblast growth factor-2 antagonistSandra Liekens, Annelies Bronckaers, Mirella Belleri, et al.
Non-Coding RNA|May 5, 2019
Circulating microRNAs and Their Role in Multiple MyelomaCinzia Federico, Antonio Sacco, Angelo Belotti, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 24, 2012
Long pentraxin 3/tumor necrosis factor-stimulated gene-6 interaction: a biological rheostat for fibroblast growth factor 2-mediated angiogenesisDaria Leali, Antonio Inforzato, Roberto Ronca, et al.
Pageof 19